<DOC>
	<DOC>NCT02244307</DOC>
	<brief_summary>The primary objective of this observational study was the assessment of prognosis factors for having recourse to prostatic surgery in patients with BPH who were administered class-1 alpha blockers. The secondary objectives were the assessment of the time from alpha-adrenergic blockade treatment initiation to surgery and the evolution of patients during the study.</brief_summary>
	<brief_title>Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Adrenergic Antagonists</mesh_term>
	<mesh_term>Adrenergic Agents</mesh_term>
	<mesh_term>Adrenergic alpha-Antagonists</mesh_term>
	<criteria>Any patient with BPH for whom alphablocker treatment is indicated Patients who are already on class1 alphablockers can only participate in the study if all information required is known and/or available Patient's followup not possible Patients participating in another study History of BPH surgery Prostate cancer</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>